Journal
CELL REPORTS
Volume 22, Issue 2, Pages 482-496Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2017.12.051
Keywords
-
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology of Japan [17KT0054, 15H04850, 15K08178]
- Japan Agency for Medical Research and Development (AMED)
- Japan Science and Technology Agency (JST) [15654757]
- Takeda Science Foundation
- Grants-in-Aid for Scientific Research [16H06276, 15K08178, 26702035, 17KT0054, 26220205, 15H04850] Funding Source: KAKEN
Ask authors/readers for more resources
A subset of mitochondrial tRNAs (mt-tRNAs) contains taurine-derived modifications at 34U of the anticodon. Loss of taurine modification has been linked to the development of mitochondrial diseases, but the molecular mechanism is still unclear. Here, we showed that taurine modification is catalyzed by mitochondrial optimization 1 (Mto1) in mammals. Mto1 deficiency severely impaired mitochondrial translation and respiratory activity. Moreover, Mto1-deficient cells exhibited abnormal mitochondrial morphology owing to aberrant trafficking of nuclear DNA-encoded mitochondrial proteins, including Opa1. The mistargeted proteins were aggregated and misfolded in the cytoplasm, which induced cytotoxic unfolded protein response. Importantly, application of chemical chaperones successfully suppressed cytotoxicity by reducing protein misfolding and increasing functional mitochondrial proteins in Mto1-deficient cells and mice. Thus, our results demonstrate the essential role of taurine modification in mitochondrial translation and reveal an intrinsic protein homeostasis network between the mitochondria and cytosol, which has therapeutic potential for mitochondrial diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available